ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

United Health Group Continues to Justify a Premium Valuation

United Health Group Continues to Justify a Premium Valuation

UnitedHealth Group (NYSE: UNH) stock is up 1.77% in late-day trading after reporting a double beat on third-quarter earnings. The gains would likely be higher but for the broader sell-off taking place in the market.  

At a time when investors are seeking value wherever they can find it, this is something that investors should take note of. However, it’s equally important to point out that United Health Group is trading at a premium to the healthcare sector. It does have the largest market cap in the sector so it may be worth it, and this article will attempt to explain why that may be.  

Business is Booming 

By any account, this was an exceptional report for United Health Group. Top-line revenue came in at $80.89 billion which was a 12% year-over-year (YOY) increase. The company cited double-digit growth in both its Optum and UnitedHealthcare units. 

On the bottom line, the results were even more impressive. The company posted earnings per share of $5.79, a 28% increase from the prior year.  

And the company’s 6.5% net margin was 16% higher than the prior year and higher than the 6.3% the company posted in the prior quarter. 

All of which is to state the obvious, demand for healthcare continues to grow.  

But if this is just about the growth of healthcare, investors may be able to find some other stocks that have a better valuation. For example, Cigna (NYSE: CI) is also delivering strong year-over-year revenue and earnings growth. But CI stock currently trades at about 17x earnings. UNH stock trades at a hefty 26.9x earnings.  

Know What You Own 

Through its Optum Labs business unit, United Health Group uses “cutting-edge analytic techniques to vast health care data sets.” Optum is attempting to address two key questions which have perplexed the industry for decades: 

  • How do you measure effective care based on health outcomes? 
  • How do you compensate providers who deliver quality care based on how a patient does in contrast to the traditional fee-for-service model? 

To that end, Optum is seeing growth in what it terms value-based payment arrangements. This means that providers can get paid more based on a how a patient does. 

And to further develop its leadership in the area of data analytics and further grow the area of value-based care, the company looks like a near lock to acquire Change Healthcare (NASDAQ: CHNG). Not only that, but acquisition such as these will help the company NYSE: UNH">lower costs and expand its services.  

UNH is a Safe Stock to Ride Out this Market 

In a risk-off market, United Health Group is offering growth in a defensive sector. However, for all the good news that United Health Group is delivering, it’s only fair to note that the stock has climbed over 166% in the last five years. It’s fair to wonder how much growth is already factored into the stock price. 

On the other hand, over the last 12 months, UNH stock has still posted a gain of over 22%. But at two different points this year, an area around $247 has acted as firm resistance for the stock.  

Nevertheless, the analysts tracked by MarketBeat give UNH stock a consensus price target of $586.40 which is a 14% gain from the stock’s current level. However, that doesn’t reflect any upcoming upgrades. As of this writing, no analyst had offered an opinion after the company’s earnings report.  

And investors get a compelling dividend that currently pays $6.60 on an annual basis, has a 1.29% yield, and has been growing for the last 12 consecutive years.  

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.